Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02387931 · ClinicalTrials.gov registry record · Phase 4
Supplementation in Adolescent Girls With Endometriosis
A Phase 4 study of Endometriosis, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT02387931 is a Phase 4 study of Endometriosis that has completed, run by Boston Children's Hospital. The registered enrollment target is 69 participants, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02387931, a Phase 4 study of Endometriosis, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether dietary supplementation with Vitamin D or Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with endometriosis.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Fish Oil
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02387931
The ClinicalTrials.gov registry entry for NCT02387931 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (74% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02387931 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02387931 about?
NCT02387931 is a clinical study titled "Supplementation in Adolescent Girls With Endometriosis". The purpose of this study is to determine whether dietary supplementation with Vitamin D or Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with endometriosis.
What is the current status of trial NCT02387931?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2014-09. Estimated completion is 2016-07.
What conditions does trial NCT02387931 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT02387931?
The interventions under investigation include: Placebo (OTHER), Vitamin D3 (DIETARY_SUPPLEMENT), Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02387931?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02387931 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
RECRUITING · Phase 4
-
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.